尊龙凯时·(中国区)人生就是搏!尊龙凯时

Recently, the the 8th Annual Society for Cardiac Robotic Navigation Meeting was successfully held in Lisbon, Portugal. This conference brought together top experts and scholars in the field of cardiac electrophysiology and robotic navigation from North America, Europe, Asia, and other countries. They shared and exchanged research findings and clinical practices centered around the theme of the application of robotic navigation technology in the field of arrhythmias and cutting-edge technological innovations.

Shanghai MicroPort EP MedTech Co., Ltd. (referred to as "MicroPort EP") actively participated in the conference with Columbus™ 3D EP Navigation System (referred to as the "Columbus™ System") magnetic navigation software, Magbot™ Magnetic Navigation Irrigated Ablation Catheter (referred to as the "Magbot™ Ablation Catheter"), and Magbot™ Magnetic Navigation High-Density Mapping Catheter.

Professor Jin Qi from Shanghai Ruijin Hospital, representing Asia, was invited to attend the meeting and shared the latest progress and Asian experiences in cardiac electrophysiology robotics. The report detailed the technical advantages of the new Magbot™ Ablation Catheter and the magnetic navigation software module of the Columbus™ System, and presented the positive results from animal trials, demonstrating its safety, efficacy, and clinical applicability.

Dr. Jose Luis Merino, the former President of the European Heart Rhythm Association, delivered a keynote speech titled "New 3D Mapping Systems for Robotics," focusing on the Columbus™ System. During his presentation, Dr. Merino shared the latest features and excellent clinical application experiences of the MicroPort EP Columbus™ System, including 3D pressure monitoring, intelligent image fusion, and multi-channel recording capabilities. He highly praised the rapid technological iteration of the product and expressed anticipation for the soon-to-be-released high-density automatic mapping function.

Two weeks prior, Dr. Merino remotely tested the magnetic navigation equipment at the MicroPort EP showroom in Shanghai, experiencing the entire process of modeling with the Magbot™ Magnetic Navigation High-Density Mapping Catheter, ablation planning and remote-controlled ablation with the Magbot™ Magnetic Navigation Ablation Catheter. He acknowledged the software's functional design and the precise remote control of the catheter, particularly praising the innovative design of the remote radiofrequency energy control function, which enables physicians to have full independent control.

Dr. Merino's impressive presentation attracted the attention of numerous overseas experts in the field of cardiac electrophysiology towards MicroPort EP's products. They visited the EverPace™ booth to experience the functions of the Columbus™ System and the design of the Magbot™ Ablation Catheter and Magbot™ Magnetic Navigation High-Density Mapping Catheter. The experts expressed their intention to visit clinical centers to observe procedures and anticipated the clinical application of MicroPort EP's full range of devices and consumables.

The Magbot™ Magnetic Navigation High-Density Mapping Catheter is currently the only locally high-density mapping product in the field of robotic magnetic navigation technology. Both the former President of the Heart Rhythm Society, Dr. Peter Weiss, and the current President, Dr. Sabine Ernst, expressed their strong anticipation for the market launch of this innovative product.

In the future, MicroPort EP will continue to strengthen cooperation with clinical experts both domestically and internationally, and continuously introduce more high-quality, innovative, and advanced medical device products to domestic and international markets. The company is committed to providing patients and doctors with more complete products and professional services, and provide electrophysiological interventional diagnosis and treatment integrated solutions with global competitiveness.